Cargando…
Antiparasitic Drugs in the United States—Two Roads to High Prices
High prescription drug prices contribute significantly to healthcare spending in the United States and compromise patients' access to quality medical care. A number of factors allow drug manufacturers to set much higher prices in the US than in other comparable high-income nations. Price-contro...
Autores principales: | Shahriar, Arman A., Alpern, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022742/ https://www.ncbi.nlm.nih.gov/pubmed/33869491 http://dx.doi.org/10.3389/fsoc.2020.540478 |
Ejemplares similares
-
Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
por: Shahriar, Arman A., et al.
Publicado: (2021) -
Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018
por: Alpern, Jonathan D., et al.
Publicado: (2020) -
Antifungal drug price increases in the United States, 2000–2019
por: Thomas, Christine M., et al.
Publicado: (2022) -
The Impact of the “Belt and Road Initiative” on International Scholarship Students
por: Shih, Lea, et al.
Publicado: (2022) -
Low Use of Standard-of-Care Antiparasitic Drugs and Increased Estimated Outpatient Payments for Treating Schistosomiasis in the United States, 2013–19
por: Joo, Heesoo, et al.
Publicado: (2022)